These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 15170359)

  • 21. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.
    Ortt K; Sinha S
    FEBS Lett; 2006 Aug; 580(18):4544-50. PubMed ID: 16870177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between human high mobility group protein 1 and replication protein A on psoralen-cross-linked DNA.
    Reddy MC; Christensen J; Vasquez KM
    Biochemistry; 2005 Mar; 44(11):4188-95. PubMed ID: 15766246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent and active p53 are identical in conformation.
    Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
    Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.
    Mouri F; Tsukada J; Mizobe T; Higashi T; Yoshida Y; Minami Y; Izumi H; Kominato Y; Kohno K; Tanaka Y
    Eur J Haematol; 2008 Jan; 80(1):10-9. PubMed ID: 18173740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topology influences p53 sequence-specific DNA binding through structural transitions within the target sites.
    Jagelská EB; Brázda V; Pecinka P; Palecek E; Fojta M
    Biochem J; 2008 May; 412(1):57-63. PubMed ID: 18271758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA binding and 3'-5' exonuclease activity in the murine alternatively-spliced p53 protein.
    Shakked Z; Yavnilovitch M; Kalb Gilboa AJ; Kessler N; Wolkowicz R; Rotter V; Haran TE
    Oncogene; 2002 Aug; 21(33):5117-26. PubMed ID: 12140762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
    Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
    Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding.
    Rippin TM; Freund SM; Veprintsev DB; Fersht AR
    J Mol Biol; 2002 May; 319(2):351-8. PubMed ID: 12051912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.
    McKinney K; Prives C
    Mol Cell Biol; 2002 Oct; 22(19):6797-808. PubMed ID: 12215537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
    Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
    J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
    Schavolt KL; Pietenpol JA
    Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
    Yang AL; Festing MF
    Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of p53 quaternary structure in relation to sequence-specific DNA binding.
    Hainaut P; Hall A; Milner J
    Oncogene; 1994 Jan; 9(1):299-303. PubMed ID: 8302593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
    Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
    BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scanning force microscopy of the complexes of p53 core domain with supercoiled DNA.
    Jett SD; Cherny DI; Subramaniam V; Jovin TM
    J Mol Biol; 2000 Jun; 299(3):585-92. PubMed ID: 10835269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2.
    Scherer SJ; Welter C; Zang KD; Dooley S
    Biochem Biophys Res Commun; 1996 Apr; 221(3):722-8. PubMed ID: 8630028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
    Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
    J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53.
    Shan B; Morris GF
    Exp Cell Res; 2005 Apr; 305(1):10-22. PubMed ID: 15777783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
    Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of the human p53 core domain in the absence of DNA.
    Wang Y; Rosengarth A; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.